147 related articles for article (PubMed ID: 12031669)
21. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
Huang JC; Zamble DB; Reardon JT; Lippard SJ; Sancar A
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10394-8. PubMed ID: 7937961
[TBL] [Abstract][Full Text] [Related]
22. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
Chow CS; Barnes CM; Lippard SJ
Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
[TBL] [Abstract][Full Text] [Related]
23. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct.
Li MJ; Yang LY
Int J Oncol; 1999 Dec; 15(6):1177-83. PubMed ID: 10568825
[TBL] [Abstract][Full Text] [Related]
24. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
Park S; Lippard SJ
Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
[TBL] [Abstract][Full Text] [Related]
25. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.
Mello JA; Acharya S; Fishel R; Essigmann JM
Chem Biol; 1996 Jul; 3(7):579-89. PubMed ID: 8807890
[TBL] [Abstract][Full Text] [Related]
26. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
27. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
[TBL] [Abstract][Full Text] [Related]
28. Recognition of platinum-DNA adducts by HMGB1a.
Ramachandran S; Temple B; Alexandrova AN; Chaney SG; Dokholyan NV
Biochemistry; 2012 Sep; 51(38):7608-17. PubMed ID: 22950413
[TBL] [Abstract][Full Text] [Related]
29. The thermodynamics of translesion DNA synthesis past major adducts of enantiomeric analogues of antitumor cisplatin.
Malina J; Novakova O; Natile G; Brabec V
Chem Asian J; 2012 May; 7(5):1026-31. PubMed ID: 22374916
[TBL] [Abstract][Full Text] [Related]
30. DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin.
Crul M; van Waardenburg RC; Bocxe S; van Eijndhoven MA; Pluim D; Beijnen JH; Schellens JH
Biochem Pharmacol; 2003 Jan; 65(2):275-82. PubMed ID: 12504803
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
Wang D; Hara R; Singh G; Sancar A; Lippard SJ
Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
[TBL] [Abstract][Full Text] [Related]
32. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.
Brabec V
Prog Nucleic Acid Res Mol Biol; 2002; 71():1-68. PubMed ID: 12102553
[TBL] [Abstract][Full Text] [Related]
33. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.
Li L; Liu X; Glassman AB; Keating MJ; Stros M; Plunkett W; Yang LY
Cancer Res; 1997 Apr; 57(8):1487-94. PubMed ID: 9108450
[TBL] [Abstract][Full Text] [Related]
34. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast.
McA'Nulty MM; Lippard SJ
Mutat Res; 1996 Jan; 362(1):75-86. PubMed ID: 8538651
[TBL] [Abstract][Full Text] [Related]
35. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
Wei M; Cohen SM; Silverman AP; Lippard SJ
J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569
[TBL] [Abstract][Full Text] [Related]
36. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
Hofr C; Farrell N; Brabec V
Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
[TBL] [Abstract][Full Text] [Related]
39. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
Stros M
Biochemistry; 2001 Apr; 40(15):4769-79. PubMed ID: 11294645
[TBL] [Abstract][Full Text] [Related]
40. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
Chao CC; Shieh TC; Huang H
FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
